Showing results (91-100 of 109) with videos related to
Sort By:
Pageof 11
International Journal of Molecular Sciences|September 14, 2024
The Impact of ARMS2 (rs10490924), VEGFA (rs3024997), TNFRSF1B (rs1061622), TNFRSF1A (rs4149576), and IL1B1 (rs1143623) Polymorphisms and Serum Levels on Age-Related Macular Degeneration Development and Therapeutic ResponsesDzastina Cebatoriene, Alvita Vilkeviciute, Greta Gedvilaite-Vaicechauskiene, et al.International Journal of Molecular Sciences|May 4, 2026
Metabolic and Genetic Alterations in Early and Exudative Age-Related Macular Degeneration: Inosine, Amino Acids, and COL2A1 Gene VariantAkvile Bruzaite, Alvita Vilkeviciute-Petraite, Dzastina Cebatoriene, et al.Biomed Research International|June 30, 2018
Association of Ki-67 Labelling Index and IL-17A with Pituitary AdenomaBrigita Glebauskiene, Rasa Liutkeviciene, Alvita Vilkeviciute, et al.Genes|September 27, 2025
First Case in Lithuania of an Autosomal Recessive Mutation in the DNAJC30 Gene as a Cause of Leber's Hereditary Optic NeuropathyLiveta Sereikaite, Alvita Vilkeviciute, Brigita Glebauskiene, et al.Genes|July 27, 2022
Association of CX36 Protein Encoding Gene GJD2 with Refractive ErrorsEdita Kunceviciene, Tomas Muskieta, Margarita Sriubiene, et al.Current Eye Research|November 11, 2011
Early age-related macular degeneration in patients with myocardial infarctionRasa Liutkeviciene, Vaiva Lesauskaite, Dalia Zaliuniene, et al.Life (Basel, Switzerland)|May 28, 2022
SIRT1: Genetic Variants and Serum Levels in Age-Related Macular DegenerationKriste Kaikaryte, Greta Gedvilaite, Alvita Vilkeviciute, et al.Journal of Clinical Medicine|June 26, 2025
The Value of Optical Coherence Tomography in Patients with Pituitary Adenoma and Its Association with Clinical Features: A Pilot StudyMonika Duseikaite, Alvita Vilkeviciute, Igne Dumbliauskaite, et al.Neuroscience Letters|April 3, 2025
Evidence for effective suppression of INa and IK(DR) by AS2034178 (bis{2-[(4-{(4'-(2-hydroxyethoxy)-2'-methyl[1,1'-biphenyl]-3-yl)methoxy}phenyl]methyl]-3,5-dioxo-1,2,4-oxadiazolidin-4-ide} tetrahydrate), an agonist of free fatty acid receptorChih-Ju Chou, Chi-Wai Cheung, Chien-Ching Lee, et al.Frontiers in Endocrinology|October 27, 2025
Associations of MEG3 rs7158663, rs4081134 gene variants and Ki-67, p53, CK18 immunohistochemical markers with clinical features of pituitary neuroendocrine tumorsBalys Remigijus Zaliunas, Enrika Pileckaite, Monika Duseikaite, et al.Pageof 11